Art

J-GLOBAL ID：201902255852583787   Reference number：19A1861514

Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones

抗糖尿病α-グルコシダーゼ阻害剤の有用性:投与時期と消化管ホルモンに及ぼす影響に関するレビュー

Author (4)： Aoki Kazutaka (Internal Medicine, Kanagawa Dental University, Yokosuka, Japan) ,  Aoki Kazutaka (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan) ,  Sato Haruhiro (Internal Medicine, Kanagawa Dental University, Yokosuka, Japan) ,  Terauchi Yasuo (Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan)
Material： Endocrine Journal (Web)
Volume： 66  Issue： 5  Page： 395-401(J-STAGE)  Publication year： 2019 
JST Material Number： U1479A  ISSN： 1348-4540  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： DPP-IV inhibitor ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1861514&from=J-GLOBAL&jstjournalNo=U1479A") }}

Author keywords (4)： Alpha-glucosidase inhibitor ,  Dipeptidyl peptidase-4 inhibitor ,  Gut hormone ,  Intake pattern

JST classification (1)： Drugs acting on metabolism in general  (GW13010F)

Reference (54)：

• 1 The DECODE study group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 354: 617-621.
• 2 DECODE study group (2002) Cardiovascular risk profile assessment in glucose-intolerant Asian individuals-an evaluation of the World Health Organization two-step strategy: the DECODA Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Asia). Diabet Med 19: 549-557.
• 3 Joshi SR, Standl E, Tong N, Shah P, Kalra S, et al. (2015) Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert Opin Pharmacother 16: 1959-1981.
• 4 Sugimoto S, Nakajima H, Kosaka K, Hosoi H (2015) Review: miglitol has potential as a therapeutic drug against obesity. Nutr Metab (Lond) eCollection 12: 51
• 5 Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, et al. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359: 2072-2077.

Terms in the title (7)： 糖尿病 ,  α-グルコシダーゼ ,  阻害剤 ,  有用性 ,  投与時期 ,  消化管ホルモン ,  レビュー